Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron in Irritable Bowel Syndrome with Diarrhoea
NCT03555188Phase 3Completed
- Sponsor
- University of Leeds
- Start
- Mar 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Irritable bowel syndrome with diarrhea (IBS-D) comparing Ondansetron with Placebo (2 arms). Primary endpoint: Weekly responder for abdominal pain and stool consistency at 12 weeks. Started Mar 2018; status: completed.
02
Drugs
ondansetron
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT03555188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03555188.